Monkey Pox: Reassuring Facts

Just what we need. Outbreak of Monkey Pox when we're still in the throes of Coronavirus!

Fortunately, there are reassuring facts. Unlike Sars-CoV-2, which was a novel, airborne virus with no vaccine, treatment, or diagnostic test, Monkey Pox is well-known, transmission so far requires physical contact, has an FDA-approved vaccine (Jynneos, 85% effective) and treatment (tecovirimat) and a diagnostic test.

The US government has already stockpiled a strategic reserve because the Monkey Pox virus is similar enough to the Small Pox virus that Jynneos and tecovirimat are effective against both. In addition, Moderna and others have initiated preclinical evaluation of mRNA vaccines to the Monkey Pox virus.

Raymond brings 20 years of biotechnology experience, at the forefront of genetic research and technologies, to develop algorithms and genetic assays that benefit human health. An innovative professional, he provides initiative and strategic direction to early-stage ventures with his unique experience in finance, business development, operations, and analysis, leading to market innovation, discovery, and increased capitalization. Dr. Peterson earned a bachelor’s in economics from the Wharton School of Business at the University of Pennsylvania, a PhD in human genetics at Pennsylvania State University, and was a fellow at the U.S. National Cancer Institute.

If you are developing a gene therapy, gene vaccine, or gene diagnostics, let him show you how DNA Analytics' AI algorithm can deliver higher quality leads that meet your design criteria in a fraction of the time and for a fraction of the normal cost.

Dr. Peterson is open to network in LinkedIn.